SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-164885
Filing Date
2024-06-21
Accepted
2024-06-20 20:31:30
Documents
15
Period of Report
2024-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d837825d8k.htm   iXBRL 8-K 27901
2 EX-99.1 d837825dex991.htm EX-99.1 12918
6 GRAPHIC g837825g0621043612821.jpg GRAPHIC 2975
  Complete submission text file 0001193125-24-164885.txt   173429

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btmd-20240614.xsd EX-101.SCH 2832
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20240614_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20240614_pre.xml EX-101.PRE 11246
18 EXTRACTED XBRL INSTANCE DOCUMENT d837825d8k_htm.xml XML 3639
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 241058155
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)